Since Treg cells derived from the TME were shown to induce CD8 T cell death via GZMB release49, we investigated whether leukemic BM-derived ST2+ Treg cells expressing high levels of GZMB can directly kill tumor effector lymphocytes (CD8+, CD4+Foxp3−, and NK cells). The gene discussed is IL1RL1; the disease is neoplasm.